Scientific rationale for a higher dose of nusinersen
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51562
Abstract: The long‐term favorable safety profile of nusinersen provides an opportunity to consider a higher dose. We report on the relationships between nusinersen cerebrospinal fluid (CSF) exposure, biomarker levels, and clinical efficacy. read more here.
Keywords: neurology; higher dose; dose nusinersen; rationale higher ... See more keywords